• Home
  • Store
    • Total Access Subscriptions
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Institutional Site Licenses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • Toolkit/AskCarlat AI
  • FAQs
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Access Purchased Content
Home » Child Psychiatry » Treating Pediatric Bipolar Disorder: More Than Just Medicine
Clinical Update

Treating Pediatric Bipolar Disorder: More Than Just Medicine

October 1, 2026
Anthony Charuvastra, MD and Roseanne Mauch, MD
From The Carlat Child Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Anthony Charuvastra, MD. Assistant Professor, Department of Child and Adolescent Psychiatry, NYU Langone, New York, NY.

Roseanne Mauch, MD. Assistant Professor, Department of Psychiatry Icahn School of Medicine at Mount Sinai, New York, NY.

Drs. Charuvastra and Mauch have no financial relationships with companies related to this material.

PDF


Getting your Trinity Audio player ready...

Ruby is a 16-year-old girl with bipolar disorder (BD) treated with lithium and low-dose quetiapine. The treatment has stabilized her mood and dissipated her anger. However, her sleep remains disrupted, her relationships with her parents are strained, and she reports continued suicidal ideation.

Family involvement is essential to treatment for youth with mood disorders. While some patients do well on medication alone, family conflict predicts suicidal ideation during depressive episodes in children, making family functioning a primary treatment target (Brent DA et al, Am J Psychiatry 2009;166(4):418–426). In pediatric BD, family-based psychosocial treatments reduce relapse rates and suicidality. Evidence-based family-inclusive treatments include family-focused therapy for adolescents (FFT-A) and dialectical behavior therapy for adolescents (DBT-A). Both demonstrate significant reductions in suicidal ideation in this population (Bahji A et al, JAMA Netw Open 2021;4(4):e216614). This article reviews family-based psychotherapy and how to help families access it.

Why psychotherapy?

Family-based psychotherapies improve core family functions (attachment, communication, cohesiveness, shared problem solving), reducing relapse and suicide risk. We explain to parents that addressing family factors is as important as medication and individual therapy. FFT-A targets familial and circadian disruptions in BD. DBT-A addresses emotional dysregulation and high-risk behaviors (eg, self-harm, suicidal ideation).

FFT-A

FFT-A is the most-studied family intervention for BD. It is conducted for 12 sessions over four months, and it covers psychoeducation, communication training, and problem-solving.

In an RCT with 127 participants, FFT-A demonstrated longer intervals between mood episodes and lower suicidal ideation over two years vs enhanced psychoeducation (Miklowitz DJ et al, J Affect Disord 2020;275:14–22). FFT-A has also been shown to halve relapse risk in at-risk kids (BD, depression) vs shorter psychoeducation, with strongest effects on depressive relapse (Miklowitz DJ et al, JAMA Psychiatry 2020;77(5):455–463). FFT-A also works to ease family conflict.

DBT-A

Lasting about four to six months, DBT-A is especially relevant for suicidal youth. In a randomized trial of 100 teens with bipolar spectrum disorder, DBT-A patients showed similar mood improvements compared with standard care, but had one-third the suicide attempts (Goldstein TR et al, JAMA Psychiatry 2024;81(1):15–24). The key skill patients learned was keeping their emotions from overwhelming them.

Shared elements of FFT-A and DBT-A

Both models:

  • Teach parents to calm their child’s emotions in the moment. FFT-A does this in joint family sessions; DBT-A uses multi-family skills groups and individual parent coaching.
  • Reduce blame, guilt, and stigma by teaching teens and caregivers that mood swings, irritability, and impulsivity reflect a brain-based vulnerability.
  • Address environmental triggers, especially family conflicts.
  • Help families validate teens’ emotions, communicate calmly, and keep the home environment supportive. This lowers relapse tied to “expressed emotion” (a home climate marked by criticism, hostility, or over-involvement).
  • Build coping mechanisms through structured modules, behavioral rehearsal, role-playing, and homework.
  • Prioritize symptom surveillance (eg, changes in sleep, speech, energy, or agitation) with plans to intervene before a full-blown episode.
  • Help teens and families navigate ambivalence about psychotropic medication.

Sleep hygiene in FFT-A vs DBT-A

Sleep disruption is both a symptom and a trigger in BD.

FFT-A treats disrupted sleep as an early warning sign. Families chart mood and sleep, tracking decreased sleep need as prodromal for mania and hypersomnia for depression. They keep consistent bed, wake, and meal times; reduce screen time to stabilize circadian rhythms; and use communication skills to reduce bedtime conflicts.

DBT-A embeds sleep in its PLEASE process for reducing teen emotionality: treat PhysicaL illness, balance Eating, Avoid mood-altering substances, balance Sleep, and get Exercise.

When racing thoughts interfere with sleep, teens use distress-tolerance skills like TIPP (Temperature, Intense Exercise, Paced Breathing, Progressive muscle relaxation) and mindfulness techniques. They also track sleep via daily diary cards.

When school or social demands interfere with sleep, teens can use the DBT-A mnemonic DEAR MAN to advocate for a more workable sleep schedule: Describe the situation, Express concerns, Assert their perspective, Reinforce why their perspective is needed, Mindfully focus on the topic (without distraction), Appear confident, Negotiate.

Diet and exercise

Evidence for nutritional supplements in pediatric BD is limited and weak. A 2023 VA/DoD review found insufficient evidence to recommend for or against their use. Physical activity data are similarly thin, although too much or little exercise can destabilize mood (Stubbs B et al, JAMA Psychiatry 2026;83(5):535–542). Adult data suggest modest benefit from combined lifestyle interventions and stronger effects from sleep-focused approaches—which are built into FFT-A and DBT-A (Simjanoski M et al, Neurosci Biobehav Rev 2023;152:105257).

Choosing between FFT-A and DBT-A

While each patient and family is unique, consider FFT-A for family conflict and DBT-A for recent self-harm.

Since Ruby’s suicidal thinking comes in the context of family conflict, you refer the family for FFT-A.

Finding FFT-A and DBT-A therapists

Advise families to start with mood disorder clinics at academic medical centers. Directories include the Behavioral Tech Directory and DBT-Linehan Board of Certification for DBT-A, and a Psychology Today keyword search for “family-focused therapy” for FFT-A. The Depression and Bipolar Support Alliance, and the National Alliance on Mental Illness, can also surface vetted providers.

Families should ask potential therapists whether they were trained specifically in FFT-A. For DBT-A, they should ask whether the program includes multi-family skills groups and individual coaching, rather than just one-on-one sessions.

If FFT-A or DBT-A is unavailable, families can look for family or group psychoeducation with skill building for illness management. This is the best-supported and most accessible approach for depressive symptoms and suicidality, though the research focuses on borderline personality disorder, not BD (de Andrade D et al, J Clin Psychol 2024;80(10):2117–2133).

After six months of FFT-A, Ruby and her parents report improved communication, fewer conflicts, and reduced suicidality.

CARLAT VERDICT

Address family systems with pediatric BD. FFT-A has the strongest evidence for reducing relapse and suicidal ideation, while DBT-A is specific for reducing suicide attempts. Include sleep and routines as part of long-term management.

Child Psychiatry
KEYWORDS DBT-A family-focused therapy pediatric bipolar disorder sleep problems suicidality
    Anthony Charuvastra, MD

    Medications for Pediatric Bipolar Disorder: Is Deprescribing an Option?

    More from this author
    Roseanne Mauch, MD
    More from this author
    www.thecarlatreport.com
    Issue Date: October 1, 2026
    SUBSCRIBE NOW
    Table Of Contents
    Learning Objectives, Bipolar Disorder in Children and Adolescents, CCPR, October/November/December 2026
    Note From the Editor-in-Chief
    Treating Pediatric Bipolar Disorder: More Than Just Medicine
    Maybe It's Not Bipolar: Rethinking Irritability in Children and Teens
    Medications for Pediatric Bipolar Disorder: Is Deprescribing an Option?
    FDA Approves Centanafadine (Simtriyo) for ADHD
    Supporting Parents of Children and Teens With Bipolar Disorder
    Antidepressant Black-Box Warnings May Have Increased Harm in Youth
    Slow Down and Individualize Antidepressant Deprescribing in Youth
    Methylphenidate vs Atomoxetine: Who Wins on ‘Other’ ADHD Symptoms?
    Atypical Antipsychotics May Promote Growth in Pediatric ARFID
    CME Post-Test, Bipolar Disorder in Children and Adolescents, CCPR, October/November/December 2026
    DOWNLOAD NOW
    Featured Book
    • CAM1e_3DCover_Spiral_sm.png

      Complementary and Alternative Medicine in Psychiatry: A Fact Book (2026) -

      Fact sheets for 67 treatments that fall outside conventional psychopharmacology.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2205347851.jpg
      General Psychiatry

      Balancing Focus and Cardiovascular Risk with ADHD Treatment

      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2026 Carlat Publishing, LLC and Affiliates, All Rights Reserved.